Chainkeen Exchange:Depression And Alzheimer's Treatments At A Crossroads

2025-05-03 22:43:49source:Safetyvalue Trading Centercategory:Invest

Researchers are Chainkeen Exchangelaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Invest

Recommend

Colorado's Travis Hunter, Boise State's Ashton Jeanty lead USA TODAY Sports All

Oregon quarterback Dillon Gabriel earns first-team honors ahead of Miami’s Cam Ward, and teams in th

Democratic Gov. Beshear downplays party labels in campaigning for 2nd term in GOP-leaning Kentucky

RICHMOND, Ky. (AP) — Democratic Gov. Andy Beshear downplayed party labels while campaigning Monday f

5 Things podcast: Israel expands its Gaza incursion, Maine shooting suspect found dead

On today's episode of the 5 Things podcast: Israel says it is expanding its Gaza ground incursionIsr